9th Meeting of the GTFCC Working Group on Oral Cholera Vaccine

October 11 - 12, 2022, Les Pensières, Center for Global Health, Veyrier-du-Lac (France)


The 9th Meeting of the Global Task Force for Cholera Control (GTFCC) Working Group on Oral Cholera Vaccine, took place on October 11-12, 2022 at Les Pensières, Center for Global Health, Veyrier du Lac, France.

The annual working group meeting aims to bring together members, countries, research institutions, funders, vaccine manufacturers, and partners supporting development, emergency response, and field implementation to strengthen the Global Taskforce for Control Cholera partnership for the OCV pillar, to review progress on WG priorities, and provide an opportunity for partners and countries to engage and collaborate.

Through active discussions, the attending working group members reviewed progress on both working group (WG) 2022 activities and deployment of OCV to reach the roadmap goals, proposed concrete action to tackle challenges, reported on priority research progress and identified any additional research needs and WG priorities for 2023. Through working sessions, WG members were invited to review and revise critical guidance documents.


  • Review key obstacles experienced during 2022
  • Celebrate partner and country successes
  • Receive 5-year OCV forecasts from countries
  • Review progress on research priorities
  • Review progress on OCV WG guidance under development
  • Discuss guiding principles for OCV allocation
  • Ratify WG priorities for 2023

Download the program

Download the report


9:15 - 9:45

Overview of the OCV use in 2022

Malika Bouhénia, OCV focal point, WHO

11:00 - 11:15

ICG perspective-challenges and workplan for OCV emergency stockpile

Salim Mohammad Reza, ICG secretariat

14:00 - 15:00

Progress on OCV working group 2022 activities

Lucy Breakwell, chair of OCV working group, CDC

OCV dashboard

Anton Camacho, Epicentre

15:00 - 15:30

OCV working group activities for 2023

Lucy Breakwell, chair of OCV working group, CDC

16:00 - 17:00

OCV research priorities

Pierre Balard, Senior Research Manager, Wellcome Trust

8:55 - 9:10

GAVI support for OCV program

Allyson Russel, GAVI & Olivia Bullock, GAVI

8:55 - 9:10

Euvichol Plus update

Rachel Park, Eubiologics

9:10 - 10:30

Sharing the experience of developing a framework for allocation of limited malaria vaccine supply

Eliane Furrer, WHO

Country updates

Bangladesh country update

Benin country update

Cameroon country update

DR Congo country update

Ethiopia country update

Kenya country update

Mozambique country update

Nepal country update

Niger country update

Somalia country update

Uganda country update